There is growing evidence that RP mutations can be found in patients with very mild or absent hematologic manifestations, as previously described, for instance, in a family with no sign of DBA where a truncating germline mutation in RPS20 cosegregated with colon cancer (Nieminen et al., 2014). Here, RPS20 is linked to malignant colon neoplasm.